Insiders · BBLG

Bruce Stroever

Director at Bone Biologics Corp (BBLG)

Bruce Stroever has filed 6 insider reports with the SEC since February 2022, as director at Bone Biologics Corp (BBLG). The latest filing, on September 30, 2026, reports grant or award at Bone Biologics Corp (BBLG).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Bruce Stroever is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Bone Biologics Corp logo
BBLG
Bone Biologics Corp
Director$0.3251Sep 30, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Bruce Stroever with

Other insiders at the same companies

Questions about Bruce Stroever

What is Bruce Stroever's role at Bone Biologics Corp?
Bruce Stroever reports to the SEC as director at Bone Biologics Corp (BBLG), according to the latest filing on September 30, 2026.
Has Bruce Stroever bought or sold stock recently?
No open-market purchases or sales by Bruce Stroever are on file. The filings report grant or award.
How do I get alerts when Bruce Stroever files?
Follow Bruce Stroever on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Bruce Stroever filed 1 time in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Bruce Stroever (SEC CIK 0001657728). Totals count each trade once, skipping amendments whose original is on file, from Feb 28, 2022 on. View on SEC EDGAR